🇨🇦 Extended Release Subcutaneous Buprenorphine in Canada

Extended Release Subcutaneous Buprenorphine (Extended Release Subcutaneous Buprenorphine) regulatory status in Canada.

Marketing authorisation

Extended Release Subcutaneous Buprenorphine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Extended Release Subcutaneous Buprenorphine approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Extended Release Subcutaneous Buprenorphine in Canada?

Royal Victoria Hospital, Canada is the originator. The local marketing authorisation holder may differ — check the official source linked above.